Display options
Share it on

Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313080.

Influence of Culture Period on Osteoblast Differentiation of Tissue-Engineered Bone Constructed by Apatite-Fiber Scaffolds Using Radial-Flow Bioreactor.

International journal of molecular sciences

Kitaru Suzuki, Jun Fukasawa, Maiko Miura, Poon Nian Lim, Michiyo Honda, Tomokazu Matsuura, Mamoru Aizawa

Affiliations

  1. Department of Applied Chemistry, School of Science and Technology, Meiji University, 1-1-1 Higashimita, Tama-ku, Kawasaki 214-8571, Kanagawa, Japan.
  2. International Institute for Materials with Life Functions, Meiji University, 1-1-1 Higashimita, Tama-ku, Kawasaki 214-8571, Kanagawa, Japan.
  3. Department of Laboratory Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105-8461, Japan.

PMID: 34884885 PMCID: PMC8657963 DOI: 10.3390/ijms222313080

Abstract

With the limitation of autografts, the development of alternative treatments for bone diseases to alleviate autograft-related complications is highly demanded. In this study, a tissue-engineered bone was formed by culturing rat bone marrow cells (RBMCs) onto porous apatite-fiber scaffolds (AFSs) with three-dimensional (3D) interconnected pores using a radial-flow bioreactor (RFB). Using the optimized flow rate, the effect of different culturing periods on the development of tissue-engineered bone was investigated. The 3D cell culture using RFB was performed for 0, 1 or 2 weeks in a standard medium followed by 0, 1 or 2 weeks in a differentiation medium. Osteoblast differentiation in the tissue-engineered bone was examined by alkaline phosphatase (ALP) and osteocalcin (OC) assays. Furthermore, the tissue-engineered bone was histologically examined by hematoxylin and eosin and alizarin red S stains. We found that the ALP activity and OC content of calcified cells tended to increase with the culture period, and the differentiation of tissue-engineered bone could be controlled by varying the culture period. In addition, the employment of RFB and AFSs provided a favorable 3D environment for cell growth and differentiation. Overall, these results provide valuable insights into the design of tissue-engineered bone for clinical applications.

Keywords: apatite-fiber scaffold; bioreactor; calcium phosphate; hydroxyapatite; rat bone marrow stem cells; tissue-engineered bone

References

  1. J Mater Sci Mater Med. 2013 May;24(5):1211-6 - PubMed
  2. Injury. 2011 Sep;42 Suppl 2:S3-15 - PubMed
  3. Biomaterials. 1986 Mar;7(2):137-43 - PubMed
  4. Acta Biomater. 2013 Jul;9(7):7490-505 - PubMed
  5. Biomaterials. 2010 May;31(13):3552-63 - PubMed
  6. Orthopedics. 2002 May;25(5 Suppl):s571-8 - PubMed
  7. Regen Ther. 2016 Jul 16;5:17-24 - PubMed
  8. Hum Cell. 2019 Jan;32(1):1-11 - PubMed
  9. Acta Biomater. 2019 Jan 1;83:435-455 - PubMed
  10. Biomaterials. 2006 Jan;27(3):315-23 - PubMed
  11. Biomaterials. 2009 Feb;30(4):499-507 - PubMed
  12. J Bone Miner Res. 1999 Dec;14(12):2118-26 - PubMed
  13. Biomed Mater Eng. 2017;28(1):57-64 - PubMed
  14. J Biomed Mater Res A. 2010 Sep 1;94(3):937-44 - PubMed
  15. World J Gastroenterol. 2006 Mar 28;12(12):1881-8 - PubMed
  16. J Mater Sci Mater Med. 2003 Mar;14(3):201-9 - PubMed
  17. Bone Joint J. 2013 May;95-B(5):583-97 - PubMed
  18. Biomater Res. 2019 Mar 14;23:9 - PubMed
  19. J Biosci Bioeng. 2005 Mar;99(3):237-44 - PubMed
  20. Biomaterials. 1998 Aug;19(15):1405-12 - PubMed
  21. Cell Tissue Res. 1988 Nov;254(2):317-30 - PubMed
  22. J Biomed Mater Res. 1970 Sep;4(3):433-56 - PubMed
  23. Biomaterials. 2021 Jan;267:120465 - PubMed
  24. Biomaterials. 2009 Sep;30(25):4117-26 - PubMed
  25. J Biomed Mater Res A. 2005 Mar 1;72(3):326-34 - PubMed
  26. Vaccine. 2020 Apr 29;38(20):3639-3645 - PubMed
  27. J Biomed Mater Res. 1997 Jul;36(1):17-28 - PubMed
  28. J Mater Sci Mater Med. 1999 Feb;10(2):111-20 - PubMed
  29. Biomaterials. 2005 Jun;26(17):3427-33 - PubMed

Publication Types

Grant support